DNA Polymerase Market - Global Industry Analysis

DNA Polymerase Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Pharmaceutical Report Format : PDF Report Code: ZMR-6588 Status : Upcoming

Description

Global DNA Polymerase Market: Overview

DNA polymerase is a kind of enzyme vital for binding nucleotides on DNA strands together. Also, it is a necessary enzyme for DNA replication. DNA polymerase is used in correcting the errors in freshly synthesized strands by a process called proofreading. During the process, the incorrect coupling is identified with the help of DNA polymerase that reverses its direction with one base pair. Incorrect segment is further eliminated by the process called excision. DNA polymerases are important for the process of translation and transcription which help in protein synthesis.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global DNA Polymerase Market: Growth Factors

There is a vast scope for the growth of the global DNA polymerase market due to the growing incidences of genetic mutations, neurological disorders, and several other chronic diseases globally. The unique characteristic of each DNA polymerase type possesses a high potential development of reagents. As an outcome, the researchers are improving on exploring new DNA polymerase variants. The thermostable DNA polymerase finds a qualitative and important role in PCR-related methodologies in the field of molecular diagnostics. The wide utilization of DNA polymerase in point-of-care kits and molecular diagnostics is likely to influence its adoption globally. According to the World Health Organization, it is expected that there will be more than 70% of cancer cases over a decade. Furthermore, the emergence of recombinant medicines for treating life-threatening diseases is likely to create several lucrative growth opportunities in the global DNA polymerase market in the forthcoming years. However, DNA polymerase is widely used in forensic testing like DNA fingerprinting to resolve many criminal cases globally. The surging application of DNA polymerases in epigenetics research coupled with rising investments in the life science sector together will escalate the growth of the market. New protein engineering methods are adopted to extract artificial or mutant DNA polymerase. Several of such DNA polymerase is built to fit particular industry-specific purposes. The growing awareness among people regarding the importance of DNA polymerase in DNA replication, repair hypermutation, mitochondrial replication, and PCB repair is likely to support the growth of the market during the forecast period. The ongoing technological innovations by key players are likely to positively impact the growth of the market. The high fidelity and hot-start DNA polymerase techniques are some of the innovations in the field of DNA polymerase and are expected to transform the whole industry by advancing the Sanger sequencing, next-generation sequencing, and colony screening assays which were previously inaccessible. The rising funding from key leaders to boost research activities will widen the scope of the market. Furthermore, the government initiatives to focus on adopting molecular diagnostics technology for the development of generic biologics will also support the market growth.

Global DNA Polymerase Market: Segmentation

The global DNA polymerase market can be segmented into end-user, application, type, and region.

By end-user, the market can be segmented into diagnostic centers, academic & research institutes, pharmaceutical & biotechnology companies, and others. The diagnostic center segment holds the domination over others.

By application, the market can be segmented into next-generation sequencing applications, SNP analysis, DNA cloning, and other applications.

By type, the market can be segmented into eukaryotic and prokaryotic DNA polymerase. The prokaryotic DNA polymerase segment accounts for the largest share in the global DNA polymerase market due to its wide range of applications in diagnostic processes like PCR tests.

Global DNA Polymerase Market: Regional analysis

North America accounts for the largest share in the global DNA polymerase market due to the high investments in the field of DNA polymerase by the prominent leaders in the region. Furthermore, the presence of a large number of contract manufacturing institutes and bioprocess organizations is likely to create several lucrative growth opportunities in the regional market in the forthcoming years. Also, the development of generic biologics coupled with the expiry of patent drugs further accentuates the growth of the regional market.

Asia Pacific is expected to be the fastest-growing region in the global DNA polymerase market due to the growing economy. Furthermore, the presence of big brands and prominent market leaders in the region will also accentuate the growth of the regional market. Also, a large number of organizations are collaborating with each other to boost their research capabilities and launch innovative products in the market. However, the fast proliferating forensic sector along with growing numbers of diagnostic centers in the region will also support the growth of the regional market.

Global DNA Polymerase Market: Competitive Players

Some of the significant players in the global DNA polymerase market are Promega Corporation, Bioline, New England Biolabs Inc., Illumina Inc., Genescript, Takara Bio Inc., Qiagen N.V., Merck KGaA, F. Hoffmann-La Roche AG, Agilent Technologies Inc., and Thermo Fisher Scientific Inc.

Global DNA Polymerase Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

There is a vast scope for the growth of the global DNA polymerase market due to the growing incidences of genetic mutations, neurological disorders, and several other chronic diseases globally. The unique characteristic of each DNA polymerase type possesses a high potential development of reagents. As an outcome, the researchers are improving on exploring new DNA polymerase variants.

Some of the significant players in the global DNA polymerase market are Promega Corporation, Bioline, New England Biolabs Inc., Illumina Inc., Genescript, Takara Bio Inc., Qiagen N.V., Merck KGaA, F. Hoffmann-La Roche AG, Agilent Technologies Inc., and Thermo Fisher Scientific Inc.

North America accounts for the largest share in the global DNA polymerase market due to the high investments in the field of DNA polymerase by the prominent leaders in the region. Furthermore, the presence of a large number of contract manufacturing institutes and bioprocess organizations is likely to create several lucrative growth opportunities in the regional market in the forthcoming years.

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social